Huitema AD - Search Results

1

Predictive ability of a semi-mechanistic model for neutropenia in the development of novel anti-cancer agents: two case studies.

Soto E, Keizer RJ, Trocóniz IF, Huitema AD, Beijnen JH, Schellens JH, Wanders J, Cendrós JM, Obach R, Peraire C, Friberg LE, Karlsson MO. Soto E, et al. Among authors: huitema ad. Invest New Drugs. 2011 Oct;29(5):984-95. doi: 10.1007/s10637-010-9437-z. Epub 2010 May 7. Invest New Drugs. 2011. PMID: 20449627 Free PMC article. Clinical Trial.

2

Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin.

Huitema AD, Spaander M, Mathĵt RA, Tibben MM, Holtkamp MJ, Beijnen JH, Rodenhuis S. Huitema AD, et al. Ann Oncol. 2002 Mar;13(3):374-84. doi: 10.1093/annonc/mdf052. Ann Oncol. 2002. PMID: 11996467 Free article.

3

Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals.

de Maat MM, Huitema AD, Mulder JW, Meenhorst PL, van Gorp EC, Beijnen JH. de Maat MM, et al. Among authors: huitema ad. Br J Clin Pharmacol. 2002 Oct;54(4):378-85. doi: 10.1046/j.1365-2125.2002.01657.x. Br J Clin Pharmacol. 2002. PMID: 12392585 Free PMC article. Clinical Trial.

4

Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.

de Jonge ME, Mathôt RA, Dalesio O, Huitema AD, Rodenhuis S, Beijnen JH. de Jonge ME, et al. Among authors: huitema ad. Bone Marrow Transplant. 2002 Nov;30(9):593-7. doi: 10.1038/sj.bmt.1703695. Bone Marrow Transplant. 2002. PMID: 12407434

5

The boosting of didanosine by allopurinol permits a halving of the didanosine dosage.

Boelaert JR, Dom GM, Huitema AD, Beijnen JH, Lange JM. Boelaert JR, et al. Among authors: huitema ad. AIDS. 2002 Nov 8;16(16):2221-3. doi: 10.1097/00002030-200211080-00016. AIDS. 2002. PMID: 12409745 No abstract available.

6

Drug interactions between antiretroviral drugs and comedicated agents.

de Maat MM, Ekhart GC, Huitema AD, Koks CH, Mulder JW, Beijnen JH. de Maat MM, et al. Among authors: huitema ad. Clin Pharmacokinet. 2003;42(3):223-82. doi: 10.2165/00003088-200342030-00002. Clin Pharmacokinet. 2003. PMID: 12603174 Review.

7

Population pharmacokinetics of itraconazole in Thai HIV-1-infected persons.

Koks CH, Huitema AD, Kroon ED, Chuenyam T, Sparidans RW, Lange JM, Beijnen JH. Koks CH, et al. Among authors: huitema ad. Ther Drug Monit. 2003 Apr;25(2):229-33. doi: 10.1097/00007691-200304000-00014. Ther Drug Monit. 2003. PMID: 12657919 Clinical Trial.

8

Subtherapeutic antiretroviral plasma concentrations in routine clinical outpatient HIV care.

de Maat MM, Huitema AD, Mulder JW, Meenhorst PL, van Gorp EC, Mairuhu AT, Beijnen JH. de Maat MM, et al. Among authors: huitema ad. Ther Drug Monit. 2003 Jun;25(3):367-73. doi: 10.1097/00007691-200306000-00018. Ther Drug Monit. 2003. PMID: 12766566

9

Simple and rapid method for the simultaneous determination of the non-nucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma using liquid chromatography.

Kappelhoff BS, Rosing H, Huitema AD, Beijnen JH. Kappelhoff BS, et al. Among authors: huitema ad. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 25;792(2):353-62. doi: 10.1016/s1570-0232(03)00325-8. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 12860043

10

Incidence and risk factors for nevirapine-associated rash.

de Maat MM, ter Heine R, Mulder JW, Meenhorst PL, Mairuhu AT, van Gorp EC, Huitema AD, Beijnen JH. de Maat MM, et al. Among authors: huitema ad. Eur J Clin Pharmacol. 2003 Sep;59(5-6):457-62. doi: 10.1007/s00228-003-0613-3. Epub 2003 Aug 12. Eur J Clin Pharmacol. 2003. PMID: 12920493

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

545 results

Search Page

Filters